Outcomes of Surgical Bioprosthetic Aortic Valve Replacement in Patients Aged ≤65 and >65 Years

Kim, 2018, Evolving trends in aortic valve replacement: a statewide experience, J Card Surg, 33, 424, 10.1111/jocs.13740 Mori, 2019, Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement, Catheter Cardiovasc Interv, 93, E337, 10.1002/ccd.27855 Carroll, 2020, STS-ACC TVT registry of transcatheter aortic valve replacement, J Am Coll Cardiol, 76, 2492, 10.1016/j.jacc.2020.09.595 Otto, 2021, 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 143, e72 Vahanian, 2021, 2021 ESC/EACTS guidelines for the management of valvular heart disease, Eur J Cardiothorac Surg, 60, 727, 10.1093/ejcts/ezab389 Korteland, 2017, Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation, Eur Heart J, 38, 3370, 10.1093/eurheartj/ehx199 Head, 2017, Mechanical versus bioprosthetic aortic valve replacement, Eur Heart J, 38, 2183, 10.1093/eurheartj/ehx141 Etnel, 2019, Bioprosthetic aortic valve replacement in nonelderly adults: a systematic review, meta-analysis, microsimulation, Circ Cardiovasc Qual Outcomes, 12, 10.1161/CIRCOUTCOMES.118.005481 Ruggieri, 2012, Long-term results of the Carpentier-Edwards supraannular aortic valve prosthesis, Ann Thorac Surg, 94, 1191, 10.1016/j.athoracsur.2012.05.003 Une, 2014, Twenty-year durability of the aortic Hancock II bioprosthesis in young patients: is it durable enough?, Eur J Cardiothorac Surg, 46, 825, 10.1093/ejcts/ezu014 Bourguignon, 2015, Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 60 or younger, Ann Thorac Surg, 100, 853, 10.1016/j.athoracsur.2015.03.105 Minakata, 2015, Long-term durability of pericardial valves in the aortic position in younger patients: when does reoperation become necessary?, J Card Surg, 30, 405, 10.1111/jocs.12537 Jamieson, 1998, Carpentier-Edwards supraannular porcine bioprosthesis evaluation over 15 years, Ann Thorac Surg, 66, S49, 10.1016/S0003-4975(98)01127-8 Schoen, 2005, Calcification of tissue heart valve substitutes: progress toward understanding and prevention, Ann Thorac Surg, 79, 1072, 10.1016/j.athoracsur.2004.06.033 Siddiqui, 2009, Bioprosthetic heart valves: modes of failure, Histopathology, 55, 135, 10.1111/j.1365-2559.2008.03190.x Tchetche, 2019, TAVR for failed surgical aortic bioprostheses using a self-expanding device: 1-year results from the prospective VIVA Postmarket Study, JACC Cardiovasc Interv, 12, 923, 10.1016/j.jcin.2019.02.029 Dauerman, 2019, Durability and clinical outcomes of transcatheter aortic valve replacement for failed surgical bioprostheses, Circ Cardiovasc Interv, 12, 10.1161/CIRCINTERVENTIONS.119.008155 David, 2010, Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability?, Ann Thorac Surg, 90, 775, 10.1016/j.athoracsur.2010.05.034 Riess, 2018, Long-term outcomes of the Mosaic bioprosthesis, Ann Thorac Surg, 105, 763, 10.1016/j.athoracsur.2017.09.053 Klautz, 2017, Safety, effectiveness and haemodynamic performance of a new stented aortic valve bioprosthesis, Eur J Cardiothorac Surg, 52, 425, 10.1093/ejcts/ezx066 Sabik, 2018, One-year outcomes associated with a novel stented bovine pericardial aortic bioprosthesis, J Thorac Cardiovasc Surg, 156, 1368, 10.1016/j.jtcvs.2018.03.171 Goldstone, 2017, Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement, N Engl J Med, 377, 1847, 10.1056/NEJMoa1613792 Chiang, 2014, Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years, JAMA, 312, 1323, 10.1001/jama.2014.12679 Stassano, 2009, Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years, J Am Coll Cardiol, 54, 1862, 10.1016/j.jacc.2009.07.032 Huckaby, 2020, Outcomes of tissue versus mechanical aortic valve replacement in patients 50 to 70 years of age, J Card Surg, 35, 2589, 10.1111/jocs.14844 Wang, 2016, Mid- to long-term outcome comparison of the Medtronic Hancock II and bi-leaflet mechancial aortic valve replacement in patients younger than 60 years of age: a propensity-matched analysis, Interact Cardiovasc Thorac Surg, 22, 280, 10.1093/icvts/ivv347 Forcillo, 2014, The Perimount valve in the aortic position: twenty-year experience with patients under 60 years old, Ann Thorac Surg, 97, 1526, 10.1016/j.athoracsur.2014.02.019 Duarte, 2001, In vivo hemodynamic, histologic, and antimineralization characteristics of the Mosaic bioprosthesis, Ann Thorac Surg, 71, 92, 10.1016/S0003-4975(00)01989-5 Weber, 2006, Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep, J Thorac Cardiovasc Surg, 132, 1137, 10.1016/j.jtcvs.2006.06.027 Celiento, 2018, Excellent durability of the Mosaic porcine aortic bioprosthesis at extended follow up, J Heart Valve Dis, 27, 97